Chimeric Antigen Receptors for the Tumour Microenvironment.

Habib, Rosemary; Nagrial, Adnan; Micklethwaite, Kenneth; Gowrishankar, Kavitha

Habib, Rosemary; Nagrial, Adnan; Micklethwaite, Kenneth; Gowrishankar, Kavitha.

Afiliação

Habib R; Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.
Nagrial A; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW, Australia.
Micklethwaite K; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW, Australia.
Gowrishankar K; Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.

Adv Exp Med Biol ; 1263: 117-143, 2020.

Article em En | MEDLINE | ID: mdl-32588326

Assuntos

Imunoterapia Adotiva; Neoplasias/terapia; Receptores de Antígenos Quiméricos; Microambiente Tumoral; Humanos; Neoplasias/imunologia; Linfócitos T/imunologia

Palavras-chave

Adoptive cell therapy (ACT); CAR; Cancer; Checkpoint receptors/checkpoint inhibitors/programmed cell death 1 receptor; Chemokine/chemokine receptor; Chimeric antigen receptor; Genetic engineering; Immunotherapy; NK-CAR; Stroma; T-cell homing; T-cell therapy; Tumour immunology; Tumour metabolism; Tumour microenvironment (TME); Vasculature

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Microambiente Tumoral / Receptores de Antígenos Quiméricos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Adv Exp Med Biol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google